Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development and validation of direct RT-LAMP for SARS-CoV-2

Abu Naser Mohon, Jana Hundt, Guido van Marle, Kanti Pabbaraju, Byron Berenger, Thomas Griener, Luiz Lisboa, Deirdre Church, Markus Czub, Alexander Greninger, Keith Jerome, Cody Doolan, Dylan R. Pillai
doi: https://doi.org/10.1101/2020.04.29.20075747
Abu Naser Mohon
1Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Hundt
1Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido van Marle
1Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanti Pabbaraju
2Alberta Public Health Laboratory, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byron Berenger
2Alberta Public Health Laboratory, Calgary, AB, Canada
3Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Griener
3Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luiz Lisboa
3Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deirdre Church
3Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada
4Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada
5Department of Medicine, University of Calgary, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Czub
6Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Greninger
7Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Jerome
8Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cody Doolan
9Illucidx Inc., Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dylan R. Pillai
1Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada
3Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada
4Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada
5Department of Medicine, University of Calgary, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drpillai@ucalgary.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We have developed a reverse-transcriptase loop mediated amplification (RT-LAMP) method targeting genes encoding the Spike (S) protein and RNA-dependent RNA polymerase (RdRP) of SARS-CoV-2. The LAMP assay achieves comparable limit of detection as commonly used RT-PCR protocols based on artificial targets, recombinant Sindbis virus, and clinical samples. Clinical validation of single-target (S gene) LAMP (N=120) showed a positive percent agreement (PPA) of 41/42 (97.62%) and negative percent agreement (NPA) of 77/78 (98.72%) compared to reference RT-PCR. Dual-target RT-LAMP (S and RdRP gene) achieved a PPA of 44/48 (91.97%) and NPA 72/72 (100%) when including discrepant samples. The assay can be performed without a formal extraction procedure, with lyophilized reagents which do need cold chain, and is amenable to point-of-care application with visual detection.

Competing Interest Statement

Patents related to LAMP technology (ANM, DRP)

Funding Statement

Funding for this study was obtained from the Canadian Institutes for Health Research (NFRFR-2019-00015, DRP) and Genome Canada (DRP), and from the M.J. Murdock Charitable Trust (KRJ).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Available upon reasonable request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 07, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of direct RT-LAMP for SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development and validation of direct RT-LAMP for SARS-CoV-2
Abu Naser Mohon, Jana Hundt, Guido van Marle, Kanti Pabbaraju, Byron Berenger, Thomas Griener, Luiz Lisboa, Deirdre Church, Markus Czub, Alexander Greninger, Keith Jerome, Cody Doolan, Dylan R. Pillai
medRxiv 2020.04.29.20075747; doi: https://doi.org/10.1101/2020.04.29.20075747
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Development and validation of direct RT-LAMP for SARS-CoV-2
Abu Naser Mohon, Jana Hundt, Guido van Marle, Kanti Pabbaraju, Byron Berenger, Thomas Griener, Luiz Lisboa, Deirdre Church, Markus Czub, Alexander Greninger, Keith Jerome, Cody Doolan, Dylan R. Pillai
medRxiv 2020.04.29.20075747; doi: https://doi.org/10.1101/2020.04.29.20075747

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (735)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)